Device Devices

Cardiva Vascade Mvp Vvcs 6-12f

Payments companies reported to CMS as associated with Cardiva Vascade Mvp Vvcs 6-12f. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$453Kassociated payments (2023-2025)
4,157clinicians with associated payments
2companies reporting

By year

2023 $147K
2024 $157K
2025 $149K

Payments reported as associated with Cardiva Vascade Mvp Vvcs 6-12f, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Clinical Cardiac Electrophysiology $210K
Cardiovascular Disease $85K
Interventional Cardiology $51K
Family $15K
Vascular Surgery $13K
Nurse Practitioner $10K

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Cardiva Vascade Mvp Vvcs 6-12f

These are the largest totals companies reported as associated with Cardiva Vascade Mvp Vvcs 6-12f. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Hugh Mcelderry Birmingham, AL Clinical Cardiac Electrophysiology $30,569.91
Nouri Al Khaled Evergreen Park, IL Cardiovascular Disease $28,308.77
David Delurgio Atlanta, GA Clinical Cardiac Electrophysiology $19,025.55
Andrea Natale Austin, TX Clinical Cardiac Electrophysiology $7,252.45
Amin Al-Ahmad Austin, TX Clinical Cardiac Electrophysiology $7,138.43
Ravi Veeraswamy Charleston, SC Vascular Surgery $6,013.68
Larry Chinitz New York, NY Clinical Cardiac Electrophysiology $5,294.44
Mayer Rashtian Pasadena, CA Clinical Cardiac Electrophysiology $5,091.31
Suneet Mittal Paramus, NJ Clinical Cardiac Electrophysiology $4,444.07
Luigi Di Biase Bronx, NY Cardiovascular Disease $4,382.07

Prescribed Cardiva Vascade Mvp Vvcs 6-12f?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.